Viewing Study NCT06823167


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-04-15 @ 6:12 AM
Study NCT ID: NCT06823167
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2025-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Sponsor: Immunome, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Malignancies View
None Hematologic Malignancies View
Keywords: